Silybin Meglumine Tablets
Function and Efficacy
Animal experiments show that this product can increase the activity of microsomal enzymes in liver cells and accelerate the liver's detoxification ability; it can also reduce the increase in serum glutamic-alanine aminotransferase in rats caused by carbon tetrachloride; it can also stabilize cell membranes of various types of liver damage caused by liver poisons such as carbon tetrachloride, phalloidine, thioacetamide, and crotalurine, thereby achieving a significant liver protection effect.
Ingredients
The active ingredient of this product is silybin meglumine.
Appearance
This product is a film-coated tablet, which appears light yellow after removing the film coating.
Indication
Used for adjuvant treatment of acute and chronic hepatitis, early cirrhosis, and toxic liver damage.
Usage and Dosage
Oral administration: 3 times a day, 100-200 mg each time, or as directed by a physician.
Adverse Reactions
Occasionally, there are reactions such as dizziness and upper abdominal discomfort.
Precautions
Not yet clear.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.
Drug Interactions
Not yet clear.
Storage
Keep away from light, sealed and stored in a dry place.
Packaging Specification
50mg
Validity Period
Tentatively 24 months.
Manufacturer
Hunan Qianjin Xieli Pharmaceutical Co., Ltd.
-
Founded in:
2003-06-26 -
Address:
No. 1361, Huanghe North Road, Tianyuan District, Zhuzhou City -
Tax NO.:
9143020075336479XF -
Registered Funds:
32 million yuan -
Website:
-
Email: